-
EP3394620
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3394620
| EP3394620 - BLADDER CANCER BIOMARKER PROTEINS [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 19.04.2024 Database last updated on 31.08.2024 | |
| Former | Grant of patent is intended Status updated on 14.12.2023 | ||
| Former | Examination is in progress Status updated on 28.11.2023 | ||
| Former | Grant of patent is intended Status updated on 18.04.2023 | ||
| Former | Examination is in progress Status updated on 15.11.2019 | ||
| Former | Request for examination was made Status updated on 28.09.2018 | ||
| Former | The international publication has been made Status updated on 05.07.2017 | ||
| Former | unknown Status updated on 27.01.2017 | Most recent event Tooltip | 19.04.2024 | (Expected) grant | published on 22.05.2024 [2024/21] | Applicant(s) | For all designated states Polyquant GmbH Industriestraße 1 93077 Bad Abbach / DE | For all designated states Commissariat à l'Energie Atomique et aux Energies Alternatives Bâtiment "Le Ponant D" 25, rue Leblanc 75015 Paris / FR | For all designated states Biomedical Research Foundation of the Academy of Athens 4 Soranou Efessiou 11527 Athens / GR | For all designated states Luxembourg Institute of Health 84, Val Fleuri 1526 Luxembourg / LU | For all designated states Institut Curie 26, rue d'Ulm 75005 Paris / FR | For all designated states Assistance Publique - Hôpitaux de Paris 3 avenue Victoria 75004 Paris / FR | For all designated states Diagnoswiss SA ZI Les Ilettes Secteur 4 PO Box 249 1870 Monthey / CH | For all designated states Fundación Centro Nacional de Investigaciones Oncológicas Carlos III C/ Melchor Fernandez Almagro 3 28029 Madrid / ES | [2018/44] | Inventor(s) | 01 /
GARIN, Jérôme Commissariat à l'Energie Atomique et aux Energies Alternatives Bâtiment le Ponant D 25 rue Leblanc 75015 Paris / FR | 02 /
MASSELON, Christophe Commissariat à l'Energie Atomique et aux Energies Alternatives Bâtiment le Ponant D 25 rue Leblanc 75015 Paris / FR | 03 /
VLAHOU, Antonia Biomedical Research Foundation of the Academy of Athens 4 Soranou Efessiou 11527 Athens / GR | 04 /
MAKRYDAKIS, Manousos Biomedical Research Foundation of the Academy of Athens 4 Soranou Efessiou 11527 Athens / GR | 05 /
ZOIDAKIS, Ieronimos Biomedical Research Foundation of the Academy of Athens 4 Soranou Efessiou 11527 Athens / GR | 06 /
DOMON, Bruno Luxembourg Institute of Health 84 Val Fleuri 1526 Luxembourg / LU | 07 /
DURIEZ, Elodie Luxembourg Institute of Health 84 Val Fleuri 1526 Luxembourg / LU | 08 /
KAMOUN, Aurélie 14 rue Corvisart 75013 Paris / FR | 09 /
RADVANYI, François Institut Curie 26 rue d'Ulm 75005 Paris / FR | 10 /
ALLORY, Yves Assistance Publique - Hopitaux de Paris 3 Avenue Victoria 75004 Paris / FR | 11 /
MALATS RIERA, Nuria Fundacion Centro Nacional de Investigaciones Oncologicas Carlos III CNIO C/ Melchor Fernández Almagro 3 28029 Madrid / ES | 12 /
MARQUEZ CID, Mirari Fundacion Centro Nacional de Investigaciones Oncologicas Carlos III CNIO C/ Melchor Fernández Almagro 3 28029 Madrid / ES | 13 /
COURT, Magali Commissariat à l'Energie Atomique et aux Energies Alternatives Bâtiment le Ponant D 25 rue Leblanc 75015 Paris / FR | [2018/44] | Representative(s) | PATERIS Patentanwälte PartmbB Postfach 33 07 11 80067 München / DE | [2024/21] |
| Former [2018/44] | PATERIS Patentanwälte PartmbB Altheimer Eck 13 80331 München / DE | Application number, filing date | 16828740.7 | 23.12.2016 | [2018/44] | WO2016EP82558 | Priority number, date | EP20150202453 | 23.12.2015 Original published format: EP 15202453 | [2018/44] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017109171 | Date: | 29.06.2017 | Language: | EN | [2017/26] | Type: | A1 Application with search report | No.: | EP3394620 | Date: | 31.10.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.06.2017 takes the place of the publication of the European patent application. | [2018/44] | Type: | B1 Patent specification | No.: | EP3394620 | Date: | 22.05.2024 | Language: | EN | [2024/21] | Search report(s) | International search report - published on: | EP | 29.06.2017 | Classification | IPC: | G01N33/574, C07K16/30, C07K7/08, C07K14/00, G01N33/68 | [2018/44] | CPC: |
G01N33/6848 (EP,US);
C07K14/54 (US);
C07K16/30 (US);
C07K7/08 (EP,US);
G01N33/57407 (EP,US);
G01N2800/52 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/44]
| Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | BLASENKREBSBIOMARKERPROTEINE | [2018/44] | English: | BLADDER CANCER BIOMARKER PROTEINS | [2018/44] | French: | PROTÉINES BIOMARQUEURS DU CANCER DE LA VESSIE | [2023/13] |
| Former [2018/44] | PROTÉINES DE BIOMARQUEUR DU CANCER DE LA VESSIE | Entry into regional phase | 18.07.2018 | National basic fee paid | 18.07.2018 | Designation fee(s) paid | 18.07.2018 | Examination fee paid | Examination procedure | 18.07.2018 | Examination requested [2018/44] | 18.07.2018 | Date on which the examining division has become responsible | 18.02.2019 | Amendment by applicant (claims and/or description) | 19.11.2019 | Despatch of a communication from the examining division (Time limit: M06) | 03.09.2020 | Reply to a communication from the examining division | 23.02.2021 | Despatch of a communication from the examining division (Time limit: M06) | 07.12.2021 | Reply to a communication from the examining division | 19.04.2023 | Communication of intention to grant the patent | 19.09.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time | 25.11.2023 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 15.12.2023 | Communication of intention to grant the patent | 15.04.2024 | Fee for grant paid | 15.04.2024 | Fee for publishing/printing paid | 15.04.2024 | Receipt of the translation of the claim(s) | Request for further processing for: | The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent | 25.11.2023 | Request for further processing filed | 25.11.2023 | Full payment received (date of receipt of payment) Request granted | 01.12.2023 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the examination report | 07.12.2021 | Request for further processing filed | 07.12.2021 | Full payment received (date of receipt of payment) Request granted | 15.12.2021 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the examination report | 03.09.2020 | Request for further processing filed | 03.09.2020 | Full payment received (date of receipt of payment) Request granted | 15.09.2020 | Decision despatched | Fees paid | Renewal fee | 18.07.2018 | Renewal fee patent year 03 | 17.12.2019 | Renewal fee patent year 04 | 21.12.2020 | Renewal fee patent year 05 | 02.11.2021 | Renewal fee patent year 06 | 22.12.2022 | Renewal fee patent year 07 | 25.10.2023 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO2008134526 (UNIV FLORIDA [US], et al); |